GAM
Groupama Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Sell |
9,921
-2,897
| -23% | -$160K | 0.01% | 318 |
|
|
2025
Q1 | $916K | Sell |
12,818
-90,606
| -88% | -$6.47M | 0.02% | 264 |
|
|
2024
Q4 | $6.77M | Buy |
103,424
+7,340
| +8% | +$480K | 0.14% | 95 |
|
|
2024
Q3 | $5.42M | Buy |
96,084
+483
| +0.5% | +$27.3K | 0.14% | 103 |
|
|
2024
Q2 | $7.87M | Buy |
95,601
+1,290
| +1% | +$106K | 0.11% | 111 |
|
|
2024
Q1 | $9.37M | Sell |
94,311
-6,442
| -6% | -$640K | 0.17% | 105 |
|
|
2023
Q4 | $9.72M | Buy |
+100,753
| New | +$9.72M | 0.25% | 76 |
|